Cell and Gene Therapy Seminar

Heidelberg, Germany

Technologiepark Heidelberg GmbH, Conference Center Im Neuenheimer Feld 582, 69120 Heidelberg

November 6, 2019

Heidelberg, Germany | Technologiepark Heidelberg GmbH, Conference Center Im Neuenheimer Feld 582, 69120 Heidelberg |

Please join us for one of our three seminars in November to hear industry experts present topics related to cell and gene therapy.

Program Agenda:

  • Manufacturing challenges for the commercialization of cell and gene therapy products
  • Risk-based approach for clinical trials of Advanced Therapy Medicinal Products (ATMP)
  • FDA regulation on biologics including cell and gene therapy products and clinical consideration on treatment of serious conditions with unmet medical needs
  • China: Update on National Medical Product Administration (NMPA) Regulation Reform
  • Logistics challenges and solutions for cell and gene therapy trials
  • Innovative reimbursement models for CAR-T and gene therapies to translate regulatory approval into reimbursement
  • Doctor’s view on how to overcome the bottle-neck in cell and gene therapy

    Speakers: 
    Mo Heidaran, VP, Technical Consulting, Parexel
    Bridget Heelan, VP, Technical Regulatory Consulting, Parexel
    Changting Haudenschild, VP, Technical Consulting, Parexel​​​​​​​
    Yuexia Li, VP, Technical Consulting, Parexel​​​​​​​
    Andrea Zobel, Senior Director, Parexel Academy​​​​​​​
    Richard Macaulay, Senior Director, Pricing and Market Access, Parexel​​​​​​​
    Lutz Uharek, Professor and Senior Physician, Charité

EVENT WEBSITE

ADD TO CALENDAR

We are always available for a conversation.

*